Clinical Trials in Tennessee

Showing 6101-6120 of 15,329 trials

Neurolens Headache Study

NCT05070767

To understand the benefits of the neurolens Measurement Device and neurolens treatment as it pertains to treating symptoms related to Chronic Headaches. It is a Prospective randomized double masked two arm performed on a minimum of 200 to a maximum of 300 subjects identified as symptomatic (HIT-6 questionnaire score equal to or greater than 56) done across 3-15 clinical sites. There are two subgroups: a minimum of 100 in each subgroup (subgroup 1: pre-presbyopic (18-40 years); subgroup 2: presbyopic subjects (41-60 years).

Binocular Vision DisorderConvergence InsufficiencyHeadache+1 more

Neurolens Inc.300 participantsStarted Oct 2021

Phoenix, Arizona, United States • Conyers, Georgia, United States • Perry, Georgia, United States +7 more locations

COMPLETEDPhase 129 miles

A Study of LY3022855 in Combination With Durvalumab or Tremelimumab in Participants With Advanced Solid Tumors

NCT02718911

The main purpose of this study is to evaluate the safety of the colony-stimulating factor 1 receptor (CSF-1R) inhibitor LY3022855 in combination with durvalumab or tremelimumab in participants with advanced solid tumors.

Solid Tumor

Eli Lilly and Company72 participantsStarted Jun 2016

Denver, Colorado, United States • Sarasota, Florida, United States • Atlanta, Georgia, United States +11 more locations

Neurolens Headache Study

A Study of LY3022855 in Combination With Durvalumab or Tremelimumab in Participants With Advanced Solid Tumors

Find Trials by Condition in Tennessee

Effects of Single Agent Niraparib and Niraparib Plus Programmed Cell Death-1 (PD-1) Inhibitors in Non-Small Cell Lung Cancer Participants

Blood Pressure After Endovascular Stroke Therapy-II

Efficacy and Safety of Olokizumab in Subjects With Moderately to Severely Active Rheumatoid Arthritis

A Study to Compare the Efficacy of SEL-212 to KRYSTEXXA® in Gout Participants Refractory to Conventional Therapy

A Phase 3 Trial to Evaluate the Safety and Efficacy of Ensifentrine in Patients With COPD

TRYHARD: Radiation Therapy Plus Cisplatin With or Without Lapatinib in Treating Patients With Head and Neck Cancer.

ANTHEM-HFrEF Pivotal Study

A Placebo-Controlled Trial of CLBS16 in Subjects With Coronary Microvascular Dysfunction

Olaparib, Cediranib Maleate, and Standard Chemotherapy in Treating Patients With Small Cell Lung Cancer

TactiSense IDE Trial of TactiCath SE for Paroxysmal Atrial Fibrillation

A Study to Evaluate AXR-159 Ophthalmic Solution in Patients With Dry Eye Disease

In-Stent Restenosis Post-Approval Study

Effect of Exeporfinium Chloride (XF-73) Gel on Nasal S.Aureus in Patients at Risk of Post-op Staphylococcal Infection

Javelin Parp Medley: Avelumab Plus Talazoparib In Locally Advanced Or Metastatic Solid Tumors

Identifying and Facilitating Ventricular Recovery on Mechanical Support

A Phase 1 Study to Evaluate FN-1501 Monotherapy in Patients With Advanced Solid Tumors and R/R AML

Safety & Efficacy Study of ORGN001 (Formerly ALXN1101) in Pediatric Patients With MoCD Type A Currently Treated With rcPMP

Pediatric Study in Children and Adolescents With Severe Plaque Psoriasis